Large-scale testing (Phase 3)Study completedNCT00006124What this trial is testingCelecoxib in Treating Patients With Bladder CancerWho this might be right forRecurrent Bladder Cancer National Cancer Institute (NCI) 152
Not applicableEnded earlyNCT04142359What this trial is testingPK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)Who this might be right forPharmacokinetics Altor BioScience 1
Testing effectiveness (Phase 2)Study completedNCT02844816What this trial is testingAtezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder CancerWho this might be right forRecurrent Bladder Urothelial CarcinomaStage 0a Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7+1 more National Cancer Institute (NCI) 172
Testing effectiveness (Phase 2)Study completedNCT03081858What this trial is testingProliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder CancerWho this might be right forBladder Cancer Cell TransitionalNon-Muscle Invasive Bladder CancerBladder Cancer+7 more Lipac Oncology LLC 15
Not applicableLooking for participantsNCT04564781What this trial is testingPredicting BCG ResponseWho this might be right forBladder Cancer Cedars-Sinai Medical Center 400
Not applicableLooking for participantsNCT07187635What this trial is testingGuiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder CancerWho this might be right forBladder CancerLiquid BiopsyRepeat Transurethral Resection of Bladder Tumor Tianjin Medical University Second Hospital 196
Large-scale testing (Phase 3)UnknownNCT04736394What this trial is testingEvaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC PatientsWho this might be right forNon-muscle Invasive Bladder Cancer Jiangsu Yahong Meditech Co., Ltd aka Asieris 800
Testing effectiveness (Phase 2)Study completedNCT00595088What this trial is testingPhase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder CancerWho this might be right forSuperficial Bladder Cancer Anchiano Therapeutics Israel Ltd. 47
Large-scale testing (Phase 3)Study completedNCT00004154What this trial is testingFenretinide in Treating Patients Who Have Undergone Surgery for Bladder CancerWho this might be right forBladder Cancer M.D. Anderson Cancer Center 111
Large-scale testing (Phase 3)Study completedNCT00445601What this trial is testingS0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerWho this might be right forBladder Cancer SWOG Cancer Research Network 406
Early research (Phase 1)Study completedNCT03258593What this trial is testingDurvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)Who this might be right forUrinary Bladder Neoplasms National Cancer Institute (NCI) 15
Not applicableLooking for participantsNCT07225127What this trial is testingComparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2Who this might be right forBladder CancerRecurrent Bladder CancerNon-muscle Invasive Bladder Cancer (NMIBC) University of Washington 408
Not applicableUnknownNCT03138837What this trial is testingRole of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and StageWho this might be right forBladder CancerDiagnoses DiseaseMagnetic Resonance Imaging+1 more Mansoura University 385
Large-scale testing (Phase 3)UnknownNCT00816075What this trial is testingEfficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral ResectionWho this might be right forRecurrent Superficial Bladder CancerDistilled Water Bozyaka Training and Research Hospital 40
Not applicableLooking for participantsNCT05672615What this trial is testingMood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCGWho this might be right forNon-Muscle Invasive Bladder Cancer Johns Hopkins University 42
Large-scale testing (Phase 3)Not Yet RecruitingNCT07198451What this trial is testingEfficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized TrialWho this might be right forNon Muscle Invasive Bladder Cancer Shanghai University of Traditional Chinese Medicine 320
Not applicableNot Yet RecruitingNCT07053748What this trial is testingObservational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing TherapyWho this might be right forHigh - Risk NMIBC Peking University First Hospital 30
Early research (Phase 1)Looking for participantsNCT05614739What this trial is testingFORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3Who this might be right forUrinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms Eli Lilly and Company 677
Testing effectiveness (Phase 2)WithdrawnNCT02143804What this trial is testingSafety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder CancerWho this might be right forBladder CancerHigh GradeNon Muscle Invasive CG Oncology, Inc.
Not applicableStudy completedNCT06126796What this trial is testingUrine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)Who this might be right forNon-muscle Invasive Bladder Cancer Mayo Clinic 107